Advancing Mitochondrial Science
The framework behind Mitome is built on a rigorous analysis of peer-reviewed scientific literature. While the specific interpretive model we use is proprietary and original, and also based on in-house analysis of the underlying test cross-referenced with comprehensive genomic and biochemical data, it is fundamentally grounded in decades of research on mitochondrial bioenergetics, nutrient biochemistry, and cellular metabolism.
What you’ll find below is not a list of studies conducted directly by our team, but rather the foundational research that informed the development of our methodology. We’ve taken what was once a test used almost exclusively for rare disease diagnosis and re-engineered its application to make it actionable for anyone seeking to optimize health, performance, and longevity at the cellular level.
This page is designed for transparency and scientific accountability—to show how we've built on the existing body of evidence to bring mitochondrial analysis into a new era of practical, personalized health optimization.

Featured Publications
Explore the research and insights advancing mitochondrial science and health.
Inhibitory effect of anti-obesity drugs on NADH dehydrogenase of mouse heart homogenates.
Published ByRes Commun Chem Pathol PharmacolPublished DateAugust 1, 1975Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer.
Published BySpringer Science and Business Media LLCPublished DateMay 31, 2022A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients.
Published ByJ Cachexia Sarcopenia MusclePublished DateFebruary 6, 2024Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin.
Published ByPortland Press Ltd.Published DateApril 1, 1989P.17.12 POLG mitochondrial myopathy presenting as a limb girdle syndrome.
Published ByElsevier BVPublished DateOctober 1, 2013The use of thiols by ribonucleotide reductase.
Published ByElsevier BVPublished DateDecember 1, 2010Deoxyribonucleoside treatment rescues EtBr-induced mtDNA depletion in iPSC-derived neural stem cells with POLG mutations.
Published ByWileyPublished DateSeptember 1, 2023The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC derived cortical organoid of Alpers’ disease.
Published ByIvyspring International PublisherPublished DateJanuary 25, 2024

Partner with Mitome™
Join the front lines of a revolution in health. We’re fighting back against decline, burnout, and biological guesswork — and we’re looking for partners who want to do the same.
Reach out to us at support@mito.me to explore affiliate and collaboration opportunities.